USE OF A TOPICAL COMPOSITION CONTAINING EPIDERMAL GROWTH FACTOR (EGF) FOR DIABETIC FOOT AMPUTATION PREVENTION

USE OF A TOPICAL COMPOSITION CONTAINING EPIDERMAL GROWTH FACTOR (EGF) FOR DIABETIC FOOT AMPUTATION PREVENTION

The invention relates to the use of topical formulations containing epidermal growth factor which is encapsulated or associated with standard or deformable liposomes, which are intended to be applied to and around chronic ischemic skin lesions. The inventive formulations, in contrast to the prior ar...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: PAEZ MEIRELES, ROLANDO, PUPO ESCALONA, ELDER, BERLANGA ACOSTA, JORGE AMADOR, BETANCOURT RODRIGUEZ, BLAS YAMIR
Format: Patent
Sprache:eng ; fre
Schlagworte:
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The invention relates to the use of topical formulations containing epidermal growth factor which is encapsulated or associated with standard or deformable liposomes, which are intended to be applied to and around chronic ischemic skin lesions. The inventive formulations, in contrast to the prior art, are useful in that they enable a high bioavailability of the epidermal growth factor in the deep tissue below the lesion and for preventing diabetic foot amputation.